Filing Details

Accession Number:
0001140361-20-006375
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-19 19:56:20
Reporting Period:
2020-03-18
Accepted Time:
2020-03-19 19:56:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1281895 Rocket Pharmaceuticals Inc. RCKT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1725929 Kinnari Patel C/o Rocket Pharmaceuticals, Inc.
350 Fifth Avenue, Suite 7530
New York NY 10118
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-18 1,000 $9.50 6,675 No 4 P Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 94,927 Indirect By Adaptive Technology LLC
Common Stock 111,738 Direct
Footnotes
  1. The shares are held indirectly through Adaptive Technology, LLC, a limited liability company that is owned and managed by the reporting person's husband.